Susan Beck | Authors



The Oncologist’s Duty to Individual Patients vs Duty to Society

June 09, 2014

The issue of value in cancer care was a prominent theme at the 2014 ASCO Annual Meeting. A question that inevitably arises in any discussion of value is what the professional and ethical obligations of practicing oncologists are in the current climate of escalating healthcare costs.

ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma

June 10, 2013

Results of two phase III trials, presented at ASCO, on the addition of bevacizumab (Avastin) to standard therapy in newly diagnosed glioblastoma found that the drug added no benefit.

ASCO: Dr. Martine Piccart, in Karnofsky Lecture, Outlines Vision for the Empowering of Academic Research

June 10, 2013

The David A. Karnofsky Memorial Award, ASCO’s highest scientific honor, went this year to Dr. Martine J. Piccart, who is internationally recognized for her unflagging dedication and innovative approaches to the development of drugs and regimens that will truly make a difference in the lives of patients with breast cancer.

ASCO: Immunotherapy for Advanced Melanoma

June 06, 2013

Building on the landmark studies of the immunotherapeutic agent ipilimumab just a few years back, ASCO 2013 saw the presentation of truly impressive data on two PD1 blockers, as well as noteworthy studies of other immunotherapeutic approaches to advanced melanoma.